Literature DB >> 23530274

Optimal interval for routine cytologic screening in the United States.

Jane J Kim, Monisha Sharma, Jesse Ortendahl.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23530274      PMCID： PMC3640804          DOI： 10.1001/2013.jamainternmed.1034

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

1.  Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

Authors:  Hans-Georg Eichler; Sheldon X Kong; William C Gerth; Panagiotis Mavros; Bengt Jönsson
Journal:  Value Health       Date:  2004 Sep-Oct       Impact factor: 5.725

Review 2.  Process of care failures in invasive cervical cancer: systematic review and meta-analysis.

Authors:  Andrea R Spence; Patricia Goggin; Eduardo L Franco
Journal:  Prev Med       Date:  2007-06-22       Impact factor: 4.018

3.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

4.  Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-06-19       Impact factor: 25.391

5.  Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.

Authors:  Katherine B Roland; Ashwini Soman; Vicki B Benard; Mona Saraiya
Journal:  Am J Obstet Gynecol       Date:  2011-06-12       Impact factor: 8.661
  5 in total
  5 in total

1.  Improving the Utilization of Human Papillomavirus and Cervical Cytology Co-testing for Cervical Cancer Screening in an Obstetrics and Gynecology Resident Clinic.

Authors:  Kurt Yoshino; Maxine Karimoto; Christina Marzo; Bliss Kaneshiro; Mark Hiraoka
Journal:  Hawaii J Med Public Health       Date:  2015-08

2.  Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines.

Authors:  Jennifer Tsui; Annika M Hofstetter; Karen Soren
Journal:  Prev Med       Date:  2014-03-17       Impact factor: 4.018

Review 3.  Cervical Cancer Screening.

Authors:  George F Sawaya; Megan J Huchko
Journal:  Med Clin North Am       Date:  2017-04-21       Impact factor: 5.456

4.  Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.

Authors:  Jane J Kim; Nicole G Campos; Stephen Sy; Emily A Burger; Jack Cuzick; Philip E Castle; William C Hunt; Alan Waxman; Cosette M Wheeler
Journal:  Ann Intern Med       Date:  2015-09-29       Impact factor: 25.391

5.  Provider beliefs associated with cervical cancer screening interval recommendations: A pilot study in Federally Qualified Health Centers.

Authors:  Katherine B Roland; April Greek; Nikki A Hawkins; Lavinia Lin; Vicki B Benard
Journal:  Prev Med Rep       Date:  2015
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.